Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation

被引：0
|
作者：
Nicolas -Xavier Bonne
Rabih Aboukais
Marc Baroncini
Audrey Hochart
Pierre Leblond
Franck Broly
Frédérique Dubrulle
Jean-Paul Lejeune
Christophe Vincent
机构：
[1] CHRU de Lille,Department of Otology and Neurotology
[2] CHRU de Lille,Department of Neurosurgery
[3] Centre Oscar Lambret,Department of Pediatric Oncology
[4] CHRU de Lille,Department of Genetic
[5] CHRU Lille,Service de Toxicologie, Génopathies
[6] CHRU Lille,Department of Radiology, Hôpital Huriez
来源：
Child's Nervous System | 2016年 / 32卷
关键词：
Neurofibromatosis type 2; Vestibular schwannoma; Middle fossa; Hearing préservation; Auditory brainstem implant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2403 / 2413
页数：10
相关论文
共 50 条
  • [31] Reduced dosage of bevacizumab in treatment of vestibular schwannomas in patients with neurofibromatosis type 2
    Farschtschi, Said
    Kollmann, Philipp
    Dalchow, Carsten
    Stein, Alexander
    Mautner, Victor-Felix
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2015, 272 (12) : 3857 - 3860
  • [32] Consequences to hearing during the conservative management of vestibular schwannomas
    Walsh, RM
    Bath, AP
    Bance, ML
    Keller, A
    Rutka, JA
    LARYNGOSCOPE, 2000, 110 (02) : 250 - 255
  • [33] Mechanism-based modeling of the clinical effects of bevacizumab and everolimus on vestibular schwannomas of patients with neurofibromatosis type 2
    Ouerdani, Aziz
    Goutagny, Stephane
    Kalamarides, Michel
    Troconiz, Inaki F.
    Ribba, Benjamin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (06) : 1263 - 1273
  • [34] Long-term clinical outcomes of stereotactic radiotherapy for bilateral vestibular schwannomas in neurofibromatosis type 2 patients
    Putipun Puataweepong
    Mantana Dhanacha
    Rawee Ruangkanchanasetr
    Keeratikarn Boonyawan
    Ake Hansasuta
    Kriangsak Saetia
    Pornpan Yongvithisatid
    Journal of Neuro-Oncology, 2023, 164 : 587 - 595
  • [35] Long-term clinical outcomes of stereotactic radiotherapy for bilateral vestibular schwannomas in neurofibromatosis type 2 patients
    Puataweepong, Putipun
    Dhanacha, Mantana
    Ruangkanchanasetr, Rawee
    Boonyawan, Keeratikarn
    Hansasuta, Ake
    Saetia, Kriangsak
    Yongvithisatid, Pornpan
    JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (03) : 587 - 595
  • [36] Mechanism-based modeling of the clinical effects of bevacizumab and everolimus on vestibular schwannomas of patients with neurofibromatosis type 2
    Aziz Ouerdani
    Stéphane Goutagny
    Michel Kalamarides
    Iñaki F. Trocóniz
    Benjamin Ribba
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 1263 - 1273
  • [37] Management of vestibular schwannomas (acoustic neuromas): Auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with Neurofibromatosis 2
    Samii, M
    Matthies, C
    Tatagiba, M
    NEUROSURGERY, 1997, 40 (04) : 696 - 705
  • [38] Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas
    Kruyt, Ivo J.
    Verheul, Jeroen B.
    Hanssens, Patrick E. J.
    Kunst, Henricus P. M.
    JOURNAL OF NEUROSURGERY, 2018, 128 (01) : 49 - 59
  • [39] Neurofibromatosis type 2.: Preliminary results of gamma knife radiosurgery of vestibular schwannomas
    Roche, PH
    Régis, J
    Pellet, W
    Thomassin, JM
    Grégoire, R
    Dufour, H
    Peragut, JC
    NEUROCHIRURGIE, 2000, 46 (04) : 339 - 353
  • [40] Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas
    Cumpston, Evan C.
    Rhodes, Steven D.
    Yates, Charles W.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (05) : 531 - 537
12345